Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
detroit blog main
detroit top stories
fda
3
×
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
3
×
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
amgen
biotech
calcitonin gene-related peptide
drugs
eli lilly
eptinezumab
erenumab
fremanezumab
galcanezumab
migraine research foundation
teva pharmaceutical
alder biopharmaceutical
What
drug
3
×
fda
new
3
×
approval
class
migraine
won
amgen
approved
arguments
big
cancer
candidates
commercialized
companies
competitors
decades
deeper
developed
dna
drugs
fingerprint
genetic
gets
going
head
make
matter
medicine
medicines
meeting
nd
neuro
nod
oks
oral
pain
potential
preventive
second
Language
Current search:
fda
×
drug
×
" seattle blog main "
×
new
×
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues
@xconomy.com
5 years ago
Amgen Migraine Drug Gets FDA Nod, First in New Class of Medicines
